























medicines and healthcare products regulatory agency - gov.uk
































cookies on gov.uk

we use some essential cookies to make this website work.
we’d like to set additional cookies to understand how you use gov.uk, remember your settings and improve government services.
we also use cookies set by other sites to help us deliver content from their services.
you have accepted additional cookies. you can change your cookie settings at any time.
you have rejected additional cookies. you can change your cookie settings at any time.




accept additional cookies
reject additional cookies
view cookies



          hide this message
        



skip to main content






gov.uk



 


        navigation menu
      



                menu


menu
 



                search gov.uk
              





                ×
              



                search gov.uk
              




 
 





                  services and information
                


benefits


births, death, marriages and care


business and self-employed


childcare and parenting


citizenship and living in the uk


crime, justice and the law


disabled people


driving and transport


education and learning


employing people


environment and countryside


housing and local services


money and tax


passports, travel and living abroad


visas and immigration


working, jobs and pensions





                  government activity
                


departments
departments, agencies and public bodies


news
news stories, speeches, letters and notices


guidance and regulation
detailed guidance, regulations and rules


research and statistics
reports, analysis and official statistics


policy papers and consultations
consultations and strategy


transparency
data, freedom of information releases and corporate reports









            search
          





search gov.uk






        search
        




 



 


 









home


organisations




medicines and healthcare products regulatory agency




medicines & healthcare productsregulatory agency






alerts, recalls and safety information: medicines and medical devices
drug safety update
yellow card: report a problem with a medicine or medical device
marketing authorisations and licensing guidance
product information about medicines 
medical devices regulation and safety
latest information for patients
mhra guidance on coronavirus (covid-19)
about mhra
all mhra services and information









    featured










nemolizumab approved to treat prurigo nodularis and atopic dermatitis (eczema) for patients in the uk
 17 february 2025 — press release


this national approval was granted after an access consortium new active substance work-sharing initiative (naswsi) procedure.

 







medical imaging agent gozetotide approved for diagnosis of prostate cancer
 12 february 2025 — press release


gozetotide binds to the cancer cells with prostate-specific membrane antigen (psma) on their surface, making them visible during the pet scan.

 







ixchiq vaccine approved to protect adults against chikungunya
  4 february 2025 — press release


the medicines and healthcare products regulatory agency (mhra) has today, 4 february 2025, approved the vaccine chikungunya vaccine (live) (brand name ixchiq) to protect adults against chikungunya disease, caused by the chikungunya virus (chikv).

 

 






digital mental health technologies guidance launched to help manufacturers and safeguard users
  3 february 2025 — press release


new guidance helps manufacturers navigate medical device regulations and protect users of digital mental health technologies.

 







mhra asks for views on proposed guidance to support the safe regulation of new personalised cancer therapies  
  3 february 2025 — press release


the draft mhra guidance aims to clarify and streamline pathways for bringing these therapies through to patients, without compromising on robust safety principles

 







aprocitentan approved to treat adults with hypertension whose blood pressure cannot be controlled by other medications
 17 january 2025 — news story


the medicines and healthcare products regulatory agency (mhra) has approved the medicine aprocitentan (jeraygo) to treat hypertension (high blood pressure) in adults whose blood pressure cannot be adequately controlled by at least three other medicines (also known as resistant hypertension).

 

 






    latest from the medicines and healthcare products regulatory agency








 nemolizumab approved to treat prurigo nodularis and atopic dermatitis (eczema) for patients in the uk




                      17 february 2025
                    


                    press release
 


 regulating medical devices in the uk




                      17 february 2025
                    


                    guidance
 


 registration of reusable or upclassified class i devices and/or expiring ce certificates




                      17 february 2025
                    


                    guidance
 




          see all latest documents
        



subscriptions


 
get emails













    what we do








the medicines and healthcare products regulatory agency regulates medicines, medical devices and blood components for transfusion in the uk.
mhra is an executive agency, sponsored by the department of health and social care.



              read more about what we do
            

 



    follow us





      the following links open in a new tab
    







 
              follow on
          
          twitter
          
            (opens in new tab)
          








 
              follow on
          
          youtube
          
            (opens in new tab)
          








 
              follow on
          
          facebook
          
            (opens in new tab)
          








 
              follow on
          
          linkedin
          
            (opens in new tab)
          








 
              follow on
          
          mhra inspectorate blog
          
            (opens in new tab)
          








 
              follow on
          
          medregs blog
          
            (opens in new tab)
          








 
              follow on
          
          instagram
          
            (opens in new tab)
          












    documents







    services




 report a problem with a medicine or medical device



 check drug analysis profiles (idaps)




            see all services
          




    guidance and regulation




 regulating medical devices in the uk




                      17 february 2025
                    


                    guidance
 


 find product information about medicines




                      19 december 2019
                    


                    guidance
 



            see all guidance and regulation
          






    news and communications




 nemolizumab approved to treat prurigo nodularis and atopic dermatitis (eczema) for patients in the uk




                      17 february 2025
                    


                    press release
 


 efanesoctocog alfa approved to prevent and treat bleeding in children and adults with severe or moderate haemophilia a




                      14 february 2025
                    


                    press release
 



            see all news and communications
          




    research and statistics




 valproate: managing reproductive risks in male patients under 55




                      13 february 2025
                    


                    research and analysis
 


 valproate: paternal exposure to valproate and risk of neurodevelopmental disorders and congenital malformations in offspring




                       5 september 2024
                    


                    research and analysis
 



            see all research and statistics
          






    policy papers and consultations




 draft guidance on individualised mrna cancer immunotherapies




                       3 february 2025
                    


                    open consultation
 


 consultation on the international council for harmonisation ich m15 guideline for model informed drug development (midd)




                      10 january 2025
                    


                    open consultation
 



            see all policy papers and consultations
          




    transparency and freedom of information releases




 mhra performance data for assessment of clinical trials and established medicines




                      14 february 2025
                    


                    transparency data
 


 mhra real-world evidence scientific dialogue programme




                      10 february 2025
                    


                    corporate report
 



            see all transparency and freedom of information releases
          









    our management










dame june raine dbe


chief executive
 







professor anthony harnden


chair
 







liz booth


chief people officer
 







rose braithwaite


chief finance officer
 









dr alison cave


chief safety officer
 







claire harrison


chief digital and technology officer
 







rachel bosworth


director of communications and engagement








carly mcgurry


director of governance










dr nicola rose


interim executive director of science and research








james pound


interim executive director, innovation and compliance








julian beach


interim executive director healthcare quality and access
 










    contact mhra





    general enquiries




            mhra10 south colonnadelondone14 4puunited kingdom



email

info@mhra.gov.uk



telephone
020 3080 6000
fax
020 3118 9803



office hours are monday to friday, 9am to 5pm.




    media enquiries




            news centremhra10 south colonnadelondone14 4puunited kingdom



email

newscentre@mhra.gov.uk



telephone (including out of hours):
020 3080 7651 








    make an foi request





            read about the freedom of information (foi) act and how to make a request.
          

            check our previous releases to see if we’ve already answered your question.
          
make a new request by contacting us using the details below.





    freedom of information




            mhra freedom of information team10 south colonnadelondone14 4puunited kingdom



email

foi.request@mhra.gov.uk



foi contact form












    corporate information





accessible documents policy
complaints procedure
our energy use
our governance
terms of reference





    jobs and contracts




procurement at mhra
working for mhra



      read our policy on social media use.
    











is this page useful?



              maybe
 


              yes this page is useful
 


              no this page is not useful
 




      thank you for your feedback
    


        report a problem with this page
 







help us improve gov.uk
don’t include personal or financial information like your national insurance number or credit card details.

this field is for robots only. please leave blank



what were you doing?




what went wrong?



send

        cancel
      








help us improve gov.uk

        to help us improve gov.uk, we’d like to know more about your visit today.
        please fill in this survey (opens in a new tab).
      

        cancel
      









services and information


benefits


births, death, marriages and care


business and self-employed


childcare and parenting


citizenship and living in the uk


crime, justice and the law


disabled people


driving and transport


education and learning


employing people


environment and countryside


housing and local services


money and tax


passports, travel and living abroad


visas and immigration


working, jobs and pensions




government activity


departments


news


guidance and regulation


research and statistics


policy papers and consultations


transparency


how government works


get involved







support links


help


privacy


cookies


accessibility statement


contact


terms and conditions


rhestr o wasanaethau cymraeg


government digital service






            all content is available under the open government licence v3.0, except where otherwise stated
          


© crown copyright








